EGIS Pharmaceutical Company – IPR-Insights License Consulting

EGIS Pharmaceutical Company

They are one of the leading generic pharmaceutical companies in Central Eastern Europe, and their activities incorporate all areas of the pharmaceutical value chain. Egis is a member of the Servier Group, an international pharmaceutical company governed by a non-profit foundation with its headquarters in France.

In the 2018/2019 financial year, Egis Group generated net sales of EUR 527 million. Their products range from active ingredients, through tablets and injections, to galenic (i.e. liquid and semi-solid) formulations and are available in 65 countries in total through their network of subsidiaries and representative offices or partners. Last financial year their portfolio consisted of 629 products that belonged to 159 product lines and contained 149 active ingredients.